The new hypertension guidelines made major changes to the classification of blood pressure, in general, and changed the name of one category to convey more importance, explained Robert Carey, MD, MACP, professor of medicine and dean emeritus at the University of Virginia.
The new hypertension guidelines made major changes to the classification of blood pressure, in general, and changed the name of one category to convey more importance, explained Robert Carey, MD, MACP, professor of medicine and dean emeritus at the University of Virginia.
Transcript
What is the importance of the new blood pressure classifications in the hypertension guideline?
We’re very excited about this guideline, because we think it will improve the health of all Americans, and we have made some major changes since the last comprehensive guideline was published in 2003. That’s called JNC 7. We took over basically from the JNC 7 program, and now have a comprehensive guideline for 2017 and going forward.
The major changes are, first of all, we have revised the classification of hypertension, and blood pressure, in general. We have lowered the upper limit of blood pressure that we consider to be dangerous, and stage 1 hypertension, which used to be defined at 140 over 90 and now is defined at 130 over 80 and above—130 over 80 and 139 over 89 is stage 1 hypertension. And above that level, stage 2 hypertension is greater than or equal to 140 over 90, which is the old stage 1.
So, we’ve lowered those limits, we have eliminated the term prehypertension, because we really didn’t think it conveyed enough importance. We’re calling that elevated blood pressure, and that’s 120 to 129 over 80 to 89.
So, if you’re less than 120 over 80, you’re normal, and if you’re 120 to 129 over 80 to 89, you have an elevated blood pressure, but it’s still not hypertensive. Then, if you go above that to 130 over 80 to 139 over 89, that’s stage 1 hypertension. And that’s a new category compared to the 2003 guideline.
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More